Literature DB >> 16564387

Clinical characteristics and survival for major salivary gland malignancies in children.

Nina L Shapiro1, Neil Bhattacharyya.   

Abstract

OBJECTIVE: Determine presentation and survival rates for malignant pediatric salivary gland neoplasms.
METHODS: All cases of malignant neoplasms involving the parotid or submandibular gland in patients ages birth to 18 years were extracted from the Surveillance, Epidemiology, and End Results database (1988-2001). Variables included age, gender, tumor histology, size, follow-up time, and vital status. Kaplan-Meier survival curves were constructed.
RESULTS: 113 primary salivary gland malignancies (103 parotid, 10 submandibular) were identified. Mean age at presentation was 13.2 years. Female:male ratio of 5:4. Mean tumor size was 2.5 cm. Among parotid tumors, there were 44 (43%) mucoepidermoid carcinomas and 35 (34%) acinic cell carcinomas. At a mean follow-up of 69.4 months, 6 (5.8%) patients with parotid malignancy were deceased; none of the submandibular malignancies were fatal. Mean Kaplan-Meier survival for parotid gland lesions was 153 months, with rhabdomyosarcomas exhibiting significantly worse survivals as compared to other malignancies (P < 0.001, log-rank test).
CONCLUSIONS: Both epithelial and mesenchymal tumors present in the pediatric salivary gland. Survival for both parotid and submandibular gland malignancies is good in children. EBM RATING: C-4.

Entities:  

Mesh:

Year:  2006        PMID: 16564387     DOI: 10.1016/j.otohns.2005.11.018

Source DB:  PubMed          Journal:  Otolaryngol Head Neck Surg        ISSN: 0194-5998            Impact factor:   3.497


  14 in total

1.  Childhood mucoepidermoid carcinoma-an interesting case.

Authors:  Mina Vaidyanathan; Richard Mark Burnham; Chris Bridle
Journal:  BMJ Case Rep       Date:  2009-03-17

2.  NUT gene rearrangement in a poorly-differentiated carcinoma of the submandibular gland.

Authors:  James Ziai; Chris A French; Eduardo Zambrano
Journal:  Head Neck Pathol       Date:  2010-03-30

3.  Locally Advanced Stage High-Grade Mucoepidermoid Carcinoma of Salivary Gland in a 9-Year-Old Girl: The Controversy of Adjuvant Therapy.

Authors:  Olga Micol Martínez; Elena Daghoum Dorado; María Dolores Amorós García; María Isabel Oviedo Ramírez; Isabel de la Fuente Muñoz; Jose Luis Fuster Soler
Journal:  Rare Tumors       Date:  2016-10-06

4.  Well-differentiated acinic cell carcinoma with lymphoid stroma associated with osteoclast-like giant cells of the parotid gland in children: a case report and literature review.

Authors:  Zhengjin Liu; Chao Pan; Ping Yin; Hongfeng Liao
Journal:  Int J Clin Exp Pathol       Date:  2018-03-01

Review 5.  [Pediatric salivary gland tumors and tumor-like lesions].

Authors:  A Agaimy; H Iro; J Zenk
Journal:  Pathologe       Date:  2017-07       Impact factor: 1.011

6.  The not-so-skinny on muscle cancer.

Authors:  Ken Kikuchi; Charles Keller
Journal:  Cancer Cell       Date:  2012-10-16       Impact factor: 31.743

7.  Salivary gland tumors in Turkey: demographic features and histopathological distribution of 510 patients.

Authors:  Yusuf Kızıl; Utku Aydil; Ozgür Ekinci; Alper Dilci; Ahmet Köybaşıoğlu; Mehmet Düzlü; Erdoğan Inal
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2012-11-10

8.  Mammary analogue secretory carcinoma of the parotid gland as a secondary malignancy in a childhood survivor of atypical teratoid rhabdoid tumor.

Authors:  Jennifer Woo; Raja R Seethala; S Joseph Sirintrapun
Journal:  Head Neck Pathol       Date:  2013-08-07

Review 9.  The case for primary salivary rhabdomyosarcoma.

Authors:  Mathew Geltzeiler; Guangheng Li; Jinu Abraham; Charles Keller
Journal:  Front Oncol       Date:  2015-04-01       Impact factor: 6.244

10.  Autoregulatory loop between TGF-β1/miR-411-5p/SPRY4 and MAPK pathway in rhabdomyosarcoma modulates proliferation and differentiation.

Authors:  M Sun; F Huang; D Yu; Y Zhang; H Xu; L Zhang; L Li; L Dong; L Guo; S Wang
Journal:  Cell Death Dis       Date:  2015-08-20       Impact factor: 8.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.